Author:
Gruben Rudolf,Holz Elena,Riethm�ller Gert
Publisher
Springer Science and Business Media LLC
Subject
Immunology,General Medicine
Reference57 articles.
1. Asano M, Yukita A, Matsumoto T, Kondo S, Suzuki H (1995) Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor 121. Cancer Res 55:5296
2. Baselga J, Fan Z, Norton L, Mendelsohn J (1994) Monoclonal antibodies directed against growth factor receptors enhance the efficacy of chemotheapeutic agents. Ann Oncol 5 [Suppl 5]:abstr no. 010
3. Baselga J, Mendelsohn J (1994) Receptor blockade with monoclonal antibodies as anti-cancer therapy. Pharmacol Ther 64:127
4. Baselga J, Norton L, Masui H, et al (1993) Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. J Natl Cancer Inst 85:1327
5. Baselga J, Tripathy D, Mendelsohn J, et al (1996) Phase II study of weekly intravenous recombinant humanized anti-P185 (HER2) monoclonal antibody in patients with HER2/NEU overexpressing metasta breast carcinoma. J Clin Oncol 14:737
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献